Clinical Trial Update: A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating THX-110 for Tourette Syndrome is reported as ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tourette Syndrome

Drugs mentioned

• THX-110

Snippet

Sponsor: Neurothera Labs Inc. | Conditions: Tourette Syndrome | Phase 2 | Status: UNKNOWN